Drug International Limited, a leading pharmaceutical company based in Bangladesh, has steadily expanded its global footprint, serving healthcare needs beyond its home country. The company is committed to providing high-quality, affordable medicines to international markets while adhering to stringent regulatory standards.

Export Markets : Drug International exports a wide range of pharmaceutical products to multiple countries across various regions, including:

South Asia: Countries like Nepal, Sri Lanka, and Bhutan benefit from Drug International’s products due to geographical proximity and regional partnerships.
Africa: The company has a growing presence in African nations, where demand for affordable and effective medicines is high. Some of the notable markets include Nigeria, Kenya, and Uganda.
Middle East: Drug International supplies its products to several countries in the Middle East, where it competes with both local and international pharmaceutical companies.
Southeast Asia: Countries like Myanmar and Vietnam also import products from Drug International, allowing the company to tap into the growing healthcare needs in these regions.

Regulatory Compliance: To meet the regulatory requirements of various countries, Drug International adheres to international standards such as:
World Health Organization (WHO) Good Manufacturing Practices (GMP)
Compliance with specific country regulations like those set by the Food and Drug Administration (FDA) or local health authorities.
These certifications ensure that the company’s products meet the global standards of safety, efficacy, and quality.

Product Portfolio for International Markets: Drug International exports a wide range of medicines in several therapeutic areas, including:
- Cardiology (Heart diseases)
- Gastroenterology (Digestive system disorders)
- Antibiotics and Antimicrobials
- Neurology (Brain and nerve conditions)
- Respiratory (Lung and breathing disorders)
- Antidiabetic Drugs
- Herbal and Nutraceutical Product
The company tailors its product offerings to meet the specific needs of different international markets, ensuring that both generic and proprietary medicines are available where required.